Jpmorgan Chase & CO En V Veno Medical Corp Transaction History
Jpmorgan Chase & CO
- $1.27 Trillion
- Q1 2025
A detailed history of Jpmorgan Chase & CO transactions in En V Veno Medical Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 194,213 shares of NVNO stock, worth $633,134. This represents 0.0% of its overall portfolio holdings.
Number of Shares
194,213
Previous 270,041
28.08%
Holding current value
$633,134
Previous $796,000
35.93%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding NVNO
# of Institutions
40Shares Held
4.49MCall Options Held
76KPut Options Held
100-
Kingdon Capital Management, L.L.C. New York, NY859KShares$2.8 Million0.41% of portfolio
-
Vanguard Group Inc Valley Forge, PA601KShares$1.96 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT597KShares$1.95 Million0.09% of portfolio
-
Act Capital Management, LLC Wayne, PA401KShares$1.31 Million3.48% of portfolio
-
Ubs Oconnor LLC Chicago, IL296KShares$965,0610.06% of portfolio
About enVVeno Medical Corp
- Ticker NVNO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 9,469,850
- Market Cap $30.9M
- Description
- enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency...